@article{b058488c760b4dcaa8a46d708968ca2f,
title = "Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?",
keywords = "B780-tropical-medicine, Protozoal diseases, Leishmaniasis, Visceral, Kala azar, Leishmania donovani, Drug therapy, Antimonials, Sodium stibogluconate, Efficacy, Treatment outcome, Drug sensitivity testing, Evaluation, Nepal, Asia-South",
author = "S Rijal and V Yardley and F Chappuis and S Decuypere and B Khanal and R Singh and M Boelaert and {De Doncker}, S and S Croft and JC Dujardin",
note = "ITG-P4B; ITG-H7A; ITG-P8B; ITG-PLA; MULTI; PARAS; U-PROTO; HEALTH; U-EPID; JIF; DOI; PDF",
year = "2007",
doi = "10.1016/j.micinf.2007.01.009",
language = "English",
volume = "9",
pages = "529--535",
journal = "Microbes and Infection",
issn = "1286-4579",
publisher = "Elsevier Masson SAS",
number = "4",
}